Handelsbanken Fonder AB Buys New Shares in LifeStance Health Group, Inc. (NASDAQ:LFST)

Handelsbanken Fonder AB acquired a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 17,400 shares of the company’s stock, valued at approximately $128,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Blue Trust Inc. boosted its stake in shares of LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after acquiring an additional 2,122 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of LifeStance Health Group by 31.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company’s stock worth $169,000 after purchasing an additional 5,767 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in shares of LifeStance Health Group by 10.5% in the third quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company’s stock worth $572,000 after purchasing an additional 7,798 shares during the period. Rhumbline Advisers lifted its stake in LifeStance Health Group by 4.5% during the fourth quarter. Rhumbline Advisers now owns 195,581 shares of the company’s stock worth $1,441,000 after purchasing an additional 8,487 shares during the last quarter. Finally, MetLife Investment Management LLC grew its position in LifeStance Health Group by 14.3% in the third quarter. MetLife Investment Management LLC now owns 80,422 shares of the company’s stock valued at $563,000 after acquiring an additional 10,084 shares during the last quarter. Institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Stock Performance

Shares of LFST opened at $7.91 on Tuesday. The company has a market capitalization of $3.03 billion, a price-to-earnings ratio of -30.42 and a beta of 1.28. The stock has a 50 day moving average of $7.81 and a 200 day moving average of $7.26. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 12 month low of $4.64 and a 12 month high of $8.61.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. William Blair reaffirmed an “outperform” rating on shares of LifeStance Health Group in a report on Friday. The Goldman Sachs Group upgraded LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a research report on Monday, December 16th. Finally, Barclays increased their price objective on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research report on Monday, November 11th. One analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, LifeStance Health Group has an average rating of “Moderate Buy” and an average price target of $8.70.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.